eli lilly glp-1 drugs Lilly's Trulicity joins pay-for-performance trend with Harvard Pilgrim deal Eli Lilly's Experimental GLP-1 Pill

Healthy weight loss maintenance with exercise, GLP-1 receptor agonist, or both combined followed by one year without treatment: a post-treatment analysis of a randomised placebo-controlled trial

Glucagon-Like Peptide 1 Modulates Calcium Responses to Glutamate and Membrane Depolarization in Hippocampal Neurons

Novo Nordisk soon followed with Victoza (liraglutide) in 2010, a once-daily injection based on a modified version of human GLP-1

Neural effects of gut- and brain-derived glucagon-like peptide-1 and its receptor agonist

These therapies have a central role in improving glycemic control and reducing cardiovascular risk

Comparison of GLP-/GIP dual agonists and GLP-1 GLP-1 and GIP, both major members of the incretin family, play a physiological role by binding and activating corresponding receptors to promote postprandial insulin secretion [125]